Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.60 |
| ▸ | MAG | P20916 | 8/20 | 0.56 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.56 |
| ▸ | SELP | P16109 | 2/20 | 0.50 |
| ▸ | SELL | P14151 | 1/20 | 0.50 |
| ▸ | SELE | P16581 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13004057 | 1.00 | SIGLEC7 (0.60) | SIGLEC7MAGCD209SELPSELL | |
| SCHEMBL14331790 | 1.00 | SIGLEC7 (0.60) | SIGLEC7MAGCD209SELPSELL | |
| SCHEMBL14570809 | 0.97 | SIGLEC7 (0.58) | SIGLEC7MAGCD209SELPSELL | |
| SCHEMBL13415599 | 0.93 | SIGLEC7 (0.56) | SIGLEC7MAGCD209SELPSELL | |
| SCHEMBL12404499 | 0.93 | SIGLEC7 (0.61) | SIGLEC7MAGCD209SELPSELL | |
| SCHEMBL13004060 | 0.90 | SIGLEC7 (0.63) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL13004041 | 0.90 | SIGLEC7 (0.65) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL30532209 | 0.90 | SIGLEC7 (0.65) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL14570812 | 0.90 | SIGLEC7 (0.60) | SIGLEC7MAGCD209SELPSELL | |
| SCHEMBL14416233 | 0.90 | SIGLEC7 (0.58) | SIGLEC7MAGCD209SELPSELL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158763-B2 | Lipophilic protected, asparagine-linked oligosaccharide derivative containing a fucose in N-acetylglucosamine on nonreducing terminal side | Kajihara, Yasuhiro (JP) | 2012-04-17 | — | — | US | disclosed |
| US-7687478-B2 | Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same | OTSUKA CHEMICAL CO., LTD. (JP) | 2010-03-30 | — | — | US | disclosed |
| US-20080214798-A1 | Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain and processes for producing these | OTSUKA CHEMCIAL CO., LTD. (JP) | 2008-09-04 | — | — | US | disclosed |
| US-20070105813-A1 | Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same | OTSUKA CHEMICAL CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105813-A1 | Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same | ASNS, FASN, SCD | SIGLEC7 329/4885MAG 407/4885CD209 1077/4885 |
| US-20080214798-A1 | Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain and processes for producing these | FUT6, B3GNT2, FUT5 | SIGLEC7 107/4885MAG 933/4885CD209 1057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.